Literature DB >> 33596964

Hemochromatosis, alcoholism and unhealthy dietary fat: a case report.

Venkatachalam Shobi1,2, Awe Adeseye3,4, Ballard Billy5,4, Kalliny Medhat6,4.   

Abstract

BACKGROUND: Hereditary hemochromatosis is an autosomal recessive disorder where the clinical phenotype of skin pigmentation and organ damage occurs only in homozygotes. Simple heterozygotes, that is, just C282Y, typically do not develop iron overload. Here we present a case where a simple heterozygote in combination with alcoholism developed high ferritin and high transferrin saturation levels indicative of iron overload. Though alcoholism alone could explain her presentation, we hypothesize that an inflammatory cocktail of iron and alcohol probably caused our patient to succumb to acute liver failure at a very young age. CASE
PRESENTATION: A 29-year-old Caucasian woman presented to the hospital with progressively worsening yellowish discoloration of her eyes and skin associated with anorexia, nausea, vomiting, diffuse abdominal discomfort, increasing abdominal girth, dark urine and pale stools for about 2 weeks. Family history was significant for hereditary hemochromatosis. Her father was a simple heterozygote and her grandmother was homozygous for C282Y. Physical examination showed scleral icterus, distended abdomen with hepatomegaly and mild generalized tenderness. Lab test results showed an elevated white blood cell count, ferritin 539 ng/dL, transferrin saturation 58.23%, elevated liver enzymes, elevated international normalized ratio (INR), low albumin, Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease (ALD/NAFLD) Index (ANI) of 2.6, suggesting a 93.2% probability of alcoholic liver disease, and phosphatidyl ethanol level of 537ng/ml. Genetic testing showed that the patient was heterozygous for human homeostatic iron regulator protein (HFE) C282Y mutation and the normal allele. Computed tomography (CT) of the abdomen revealed hepatomegaly, portal hypertension and generalized anasarca. Magnetic resonance cholangiopancreatography (MRCP) showed negative results for bile duct pathology. Workup for other causes of liver disease was negative. A diagnosis of acute alcoholic hepatitis was made, with Maddrey's discriminant function of > 32, so prednisolone was started. Her bilirubin and INR continued to increase despite steroids, and the patient unfortunately died.
CONCLUSION: Our case highlights the importance of considering hemochromatosis in the differential diagnosis of young patients presenting with liver failure, including cases suggestive of alcoholism as the likely etiology. Larger studies are needed to investigate the role of non-iron factors like alcohol and viral hepatitis in the progression of liver disease in simple heterozygotes with hereditary hemochromatosis, given the high prevalence of this mutation in persons of Northern European descent.

Entities:  

Keywords:  Alcoholism; Case report; Hereditary hemochromatosis; Unhealthy diet

Mesh:

Substances:

Year:  2021        PMID: 33596964      PMCID: PMC7888131          DOI: 10.1186/s13256-020-02610-7

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  11 in total

1.  Do eating habits differ according to alcohol consumption? Results of a study of the French cohort of the European Prospective Investigation into Cancer and Nutrition (E3N-EPIC).

Authors:  E Kesse; F Clavel-Chapelon; N Slimani; M van Liere
Journal:  Am J Clin Nutr       Date:  2001-09       Impact factor: 7.045

Review 2.  Epidemiology and diagnostic testing for hemochromatosis and iron overload.

Authors:  P C Adams
Journal:  Int J Lab Hematol       Date:  2015-05       Impact factor: 2.877

3.  Natural history of HFE simple heterozygosity for C282Y and H63D: a prospective 12-year study.

Authors:  Sophie G Zaloumis; Katrina J Allen; Nadine A Bertalli; Lidija Turkovic; Martin B Delatycki; Amanda J Nicoll; Christine E McLaren; Dallas R English; John L Hopper; Graham G Giles; Gregory J Anderson; John K Olynyk; Lawrie W Powell; Lyle C Gurrin
Journal:  J Gastroenterol Hepatol       Date:  2015-04       Impact factor: 4.029

4.  Clinical and biochemical abnormalities in people heterozygous for hemochromatosis.

Authors:  Z J Bulaj; L M Griffen; L B Jorde; C Q Edwards; J P Kushner
Journal:  N Engl J Med       Date:  1996-12-12       Impact factor: 91.245

5.  Iron-overload-related disease in HFE hereditary hemochromatosis.

Authors:  Katrina J Allen; Lyle C Gurrin; Clare C Constantine; Nicholas J Osborne; Martin B Delatycki; Amanda J Nicoll; Christine E McLaren; Melanie Bahlo; Amy E Nisselle; Chris D Vulpe; Gregory J Anderson; Melissa C Southey; Graham G Giles; Dallas R English; John L Hopper; John K Olynyk; Lawrie W Powell; Dorota M Gertig
Journal:  N Engl J Med       Date:  2008-01-17       Impact factor: 91.245

Review 6.  Pathogenesis of Alcoholic Liver Disease.

Authors:  Winston Dunn; Vijay H Shah
Journal:  Clin Liver Dis       Date:  2016-03-28       Impact factor: 6.126

Review 7.  Mechanisms of NAFLD development and therapeutic strategies.

Authors:  Scott L Friedman; Brent A Neuschwander-Tetri; Mary Rinella; Arun J Sanyal
Journal:  Nat Med       Date:  2018-07-02       Impact factor: 53.440

8.  HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity.

Authors:  Lyle C Gurrin; Nadine A Bertalli; Gregory W Dalton; Nicholas J Osborne; Clare C Constantine; Christine E McLaren; Dallas R English; Dorota M Gertig; Martin B Delatycki; Amanda J Nicoll; Melissa C Southey; John L Hopper; Graham G Giles; Gregory J Anderson; John K Olynyk; Lawrie W Powell; Katrina J Allen
Journal:  Hepatology       Date:  2009-07       Impact factor: 17.425

9.  Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study.

Authors:  Elliot B Tapper; Neehar D Parikh
Journal:  BMJ       Date:  2018-07-18

Review 10.  Iron and liver fibrosis: Mechanistic and clinical aspects.

Authors:  Kosha J Mehta; Sebastien Je Farnaud; Paul A Sharp
Journal:  World J Gastroenterol       Date:  2019-02-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.